Clinical Trial Update: 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Menostar (estradiol patch) to Evista (raloxifene) for osteoporosis prevention in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Evista (raloxifene)
• MENOSTAR (ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Osteopenia | Phase 3 | Status: COMPLETED